HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Khalid Al-Rasadi Selected Research

Kepar

10/2015Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients With Metabolic Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Khalid Al-Rasadi Research Topics

Disease

21Cardiovascular Diseases (Cardiovascular Disease)
09/2023 - 10/2010
13Atherosclerosis
11/2022 - 01/2015
9Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2022 - 01/2013
8COVID-19
05/2023 - 01/2020
6Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2023 - 10/2015
6Inflammation (Inflammations)
11/2022 - 01/2020
6Coronary Disease (Coronary Heart Disease)
10/2022 - 10/2010
5Hypercholesterolemia
03/2022 - 07/2014
4Obesity
12/2023 - 01/2016
4Type 2 Diabetes Mellitus (MODY)
05/2023 - 01/2015
4Vascular Diseases (Vascular Disease)
04/2021 - 07/2014
3Insulin Resistance
12/2023 - 01/2016
3Coronary Artery Disease (Coronary Atherosclerosis)
12/2023 - 07/2019
3Body Weight (Weight, Body)
11/2022 - 01/2015
3Infections
01/2022 - 11/2020
3Dyslipidemias (Dyslipidemia)
01/2022 - 01/2021
3Non-alcoholic Fatty Liver Disease
01/2021 - 06/2014
3Hypertension (High Blood Pressure)
04/2020 - 01/2018
2Morbid Obesity
12/2023 - 01/2021
2Homozygous Familial Hypercholesterolemia
07/2023 - 01/2015
2Stroke (Strokes)
08/2021 - 01/2017
2Myocardial Infarction
07/2021 - 01/2017
2Atherosclerotic Plaque (Atheroma)
04/2021 - 01/2021
2Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
06/2015 - 03/2015
2Acute Coronary Syndrome
04/2011 - 01/2011
1Portal Hypertension
09/2023
1Psychotic Disorders (Schizoaffective Disorder)
11/2022
1Weight Loss (Weight Reduction)
07/2022
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
06/2022
1Critical Illness (Critically Ill)
06/2022
1Vasculitis (Vasculitides)
06/2022
1Cytokine Release Syndrome
01/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
1Hyperlipoproteinemia Type IV (Type IV, Hyperlipoproteinemia)
01/2022
1Ischemic Stroke
07/2021
1Osteoporosis
07/2021
1Arthritis (Polyarthritis)
07/2021

Drug/Important Bio-Agent (IBA)

23Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2023 - 10/2010
19LipidsIBA
01/2022 - 03/2014
16oxidized low density lipoproteinIBA
12/2023 - 10/2010
15LDL CholesterolIBA
09/2023 - 11/2014
9CholesterolIBA
11/2022 - 04/2011
7HDL CholesterolIBA
03/2022 - 01/2011
6Glucose (Dextrose)FDA LinkGeneric
12/2023 - 10/2015
5LDL Receptors (LDL Receptor)IBA
01/2022 - 01/2013
4Triglycerides (Triacylglycerol)IBA
12/2023 - 01/2022
4Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2013
3Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2015
3CurcuminIBA
01/2022 - 01/2020
3ApolipoproteinsIBA
02/2018 - 11/2014
2CytokinesIBA
12/2022 - 01/2020
2Lipoproteins (Lipoprotein)IBA
11/2022 - 01/2015
2AntioxidantsIBA
01/2022 - 01/2021
2PhytochemicalsIBA
01/2022 - 01/2021
2EnzymesIBA
01/2021 - 01/2021
2VaccinesIBA
01/2021 - 01/2021
2Glucagon-Like Peptide-1 ReceptorIBA
01/2021 - 01/2015
2DNA (Deoxyribonucleic Acid)IBA
12/2020 - 01/2013
2SultanIBA
05/2020 - 07/2011
2Antiviral Agents (Antivirals)IBA
01/2020 - 05/2016
2Adenosine Triphosphate (ATP)IBA
01/2018 - 11/2014
2Complement System Proteins (Complement)IBA
06/2015 - 03/2015
2Apolipoproteins B (ApoB)IBA
12/2014 - 11/2014
1Glucagon-Like Peptide 1 (GLP 1)IBA
05/2023
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2023
1Interleukin-4 (Interleukin 4)IBA
12/2022
1AdipokinesIBA
12/2022
1Interleukin-10 (Interleukin 10)IBA
12/2022
1Interleukin-8 (Interleukin 8)IBA
12/2022
1Interleukin-6 (Interleukin 6)IBA
12/2022
1Interferon-gamma (Interferon, gamma)IBA
12/2022
1Interleukin-2 (IL2)IBA
12/2022
1lipopolysaccharide-binding proteinIBA
11/2022
1Olanzapine (Zyprexa)FDA Link
11/2022
1LipopolysaccharidesIBA
11/2022
1cyclo(Arg-Pro) (CI 4)IBA
11/2022
1Hydrocortisone (Cortisol)FDA LinkGeneric
06/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2022
1GlucocorticoidsIBA
06/2022
1hydrocortisone receptorIBA
06/2022
1Adrenocorticotropic Hormone (ACTH)FDA Link
06/2022
1BerberineIBA
01/2022
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
08/2021
1PCSK9 InhibitorsIBA
04/2021
1SubtilisinIBA
04/2021
1CalciumIBA
04/2021
1Hypolipidemic Agents (Antihyperlipidemics)IBA
04/2021
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
04/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2021
1ALN-PCSIBA
04/2021
18- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
04/2021
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
04/2021
1InflammasomesIBA
04/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2021
1PotassiumIBA
03/2021
1Potassium Channels (Potassium Channel)IBA
03/2021

Therapy/Procedure

5Therapeutics
01/2021 - 10/2010
4Bariatric Surgery
12/2023 - 01/2021
2Secondary Prevention
01/2017 - 10/2010
1Duration of Therapy
06/2022